Dewayne Johnson, a former school groundskeeper, became the first plaintiff to win a jury verdict against glyphosate-based herbicides, establishing a pivotal legal precedent on liability and safety debates. This verified explainer details the timeline, evidence, and outcomes of the case, offering a clear, durable reference independent of ongoing news cycles. It focuses on confirmed findings, court records, and regulatory responses rather than speculation.
The Core Facts of the Johnson Case
In 2018, a California jury awarded Dewayne Johnson $289 million in damages after finding that Monsanto’s glyphosate-based herbicide Roundup was a substantial factor in his development of non-Hodgkin lymphoma. The verdict highlighted failures in warning labels and alleged efforts to influence scientific assessments of glyphosate. Below is a concise overview of key attributes and milestones confirmed by court records and public documents.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Plaintiff | Dewayne Johnson | Court filings |
| Initial Award (2018) | $289 million (later modified) | Court judgment; trial records |
| Product | Roundup (glyphosate-based herbicide) | Product labeling; regulatory filings |
| Alleged Health Effect | Non-Hodgkin lymphoma | Medical records; trial testimony |
| Key Legal Finding | Failure to warn; glyphosate a substantial factor | Jury verdict; judge’s instructions |
| Year of First Verdict | 2018 | Public court records |
Initial Trial and Judgment
The trial emphasized the adequacy of Monsanto’s warnings, internal email disclosures, and the scientific evidence presented by both sides. The jury determined that Roundup was a substantial factor in Johnson’s illness and that the company failed to provide sufficient warnings, resulting in the initial punitive and compensatory damages award. Subsequent legal proceedings led to modifications of the award and multiple appeals.
Appeals and Final Resolution
Over several years, the case moved through multiple appeals and settlements. In 2020, Monsanto, by then owned by Bayer, reached an $86.7 million settlement with Johnson. Later rulings further adjusted terms, emphasizing the importance of evidence disclosure and adherence to safety assessments under California law.
Legal and Regulatory Impact
The Johnson case remains a landmark in product liability, shaping how courts and regulators evaluate warning labels, chemical risk assessments, and corporate responsibility. It intensified scrutiny of glyphosate and prompted increased transparency requirements and new warnings in certain jurisdictions.
- Higher standards for warning labels on pesticides
- Increased discovery obligations regarding internal research
- Greater judicial scrutiny of industry-funded science
Comparison to Similar Cases
While Johnson was the first major jury verdict, subsequent cases have followed varied outcomes. The table below contrasts key attributes across notable glyphosate-related cases involving product liability claims.
| Case | Award/Settlement | Year | Status |
|---|---|---|---|
| Dewayne Johnson | $289M initial; $86.7M settlement (2020) | 2018–2020 | Settled |
| Edwin Hardeman | $75M (post-trial phase) | 2020 | Judgment modified; appeals resolved |
| Klein v. Bayer Corp | $2.0B (punitive) — later reduced | 2020 | Appeals ongoing; settlements pursued |
| Bates et al. (MDL) | Multi-district litigation; varied settlements | 2019–present | Ongoing; case-specific outcomes |
Current Relevance and Public Understanding
The ruling continues to inform public understanding of risk communication in agriculture, landscaping, and residential use. Courts and regulatory bodies frequently reference the case when assessing compliance, duty of care, and the adequacy of hazard warnings.
Conclusion
The Dewayne Johnson case remains a cornerstone in product liability discussions, particularly around glyphosate and chemical safety. It underscores the long-term significance of clear warnings, transparent research practices, and the judiciary’s role in addressing complex scientific and health questions.